1194 / 1345
133 109 75 47 32 16 4 1
96 80 69 46 29 15 4 0
115 79 62 45 32 13 6 1
86 58 46 39 27 6 4 2
Incontinence G≥2 and
EMBRACE I cohort
5 centers included
Patients with Bladder wall infiltration excluded
Patients with Baseline morbidity assessment
and at least one Follow Up included
451 patients
CTC Grade
0
258
1
128
2
48
3
4
4
1
ICRU bladder point dose
representing bladder trigonum
dose
Spampinato, Tanderup et al. Work in progress
Dose constraint:
<65 Gy
Up to 9% G≥2
work in progress: